Figure 6.
Mixed effect regression of individual cellular and plasma biomarkers in subsets of pediatric cGVHD. (A) Pulmonary cGVHD (n = 12). (B) De novo cGVHD (n = 7). (C) Progressive cGVHD (including all cases of overlap syndrome) (n = 18).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.